$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018
Lloyd Price
JULY 5, 2018
This was the biggest deal for GSK since Emma Walmsley took over the reins of the company last year. The deal gave GSK 100 percent control of the business unit that markets products such as Sensodyne toothpaste and Panadol headache tablets. In April, GSK divested its rare disease gene therapy portfolio to Orchard Therapeutics for a 19.9
40 
Let's personalize your content